Company Performance Metrics
Robert Rhinehart: Founder and President
Galina Izykenova: Chief Technology Officer
The Company was incorporated August 2, 2000, and is a research and development company focused on bringing to the marketplace unique disease-associated biomarkers and in-vitro diagnostic (IVD) tools to fulfill unmet needs in serological assessment of stroke or brain attack. CIS Biotech is primarily engaged in research, development, and marketing
of products in the cerebrovascular and cardiovascular disease area and in diabetes.
CIS Biotech has developed proprietary cost-effective test kits that shorten the time required by a physician to diagnose the type of stroke accurately and initiate appropriate treatment. Using just a few drops of a patient’s blood, the test kits:
a. require no supporting diagnostic equipment,
b. deliver timely and highly reliable diagnostic results,
c. are considerably less expensive than other
diagnostic regimens, and
d. are user-friendly.
